Standalone Sep 2026 quarter: revenue up 11% to Rs 1,043.16 lakh; after-tax loss Rs 89.71 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone results for the quarter ended 30 September 2026 showed revenue from operations of Rs 1,043.16 lakh, up 11.1% from Rs 939.15 lakh a year earlier, but profit after tax was a loss of Rs 89.71 lakh versus a profit of Rs 116.28 lakh. Half-year profit after tax was a loss of Rs 19.75 lakh and operating cash flow was negative. Borrowings far exceeded Rs 6.45 lakh of equity. The signature correction did not change the numbers.
Sales growth did not prevent a quarterly loss, weaker margins, negative cash flow or high debt versus equity; this may weigh on the share price.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹12.03 Cr | ₹5.53 Cr | +117.3% |
| Operating profit | −₹0.92 Cr | −₹0.63 Cr | loss widened |
| Profit after tax | −₹0.90 Cr | −₹0.60 Cr | loss widened |
| EBITDA margin | -4.3% | -3.9% | −0.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.